Poor Recognition of Risk Factors for Hepatitis B by Physicians Prescribing Immunosuppressive Therapy: A Call for Universal Rather than Risk-Based Screening

BACKGROUND: Reactivation of hepatitis B virus (HBV) during immunosuppressive therapy (IST) can lead to severe and even fatal hepatitis but can be largely prevented with prophylactic antiviral therapy. Screening for HBV prior to starting IST is recommended. Both risk-based and universal screening hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Visram, Alissa, Chan, Kelvin K. W., McGee, Phyllis, Boro, Jordana, Hicks, Lisa K., Feld, Jordan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398053/
https://www.ncbi.nlm.nih.gov/pubmed/25875198
http://dx.doi.org/10.1371/journal.pone.0120749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398053/
https://www.ncbi.nlm.nih.gov/pubmed/25875198
http://dx.doi.org/10.1371/journal.pone.0120749

Ejemplares similares